Page results
-
UCLH has retendered and awarded five-year contracts to two companies to provide estates and facilities services across UCLH.
-
Information about travelling to your appointment for UCLH cancer services and different locations and hospitals.
-
UCLH chair Baroness Julia Neuberger has today announced that Professor Marcel Levi will be stepping down from his role as UCLH chief executive on 31 March 2021.
-
UCLH will be part of a first-of-its kind clinical trial, led by scientists at UCL, that will evaluate the use of ‘real time’ viral genomic data to reduce the spread of COVID-19 within hospitals.
-
Today is the 72 anniversary of the NHS – and it is dedicated to our amazing staff.
-
The North Central London Integrated Care System (NCL ICS) has new services and staff training to support patients with inherited red cell disorders, including Sickle Cell and Thalassaemia, living in Barnet, Camden, Enfield, Haringey and Islington.
-
The emergency department at University College Hospital is set to undergo an ambitious refurbishment project of the resuscitation (resus) area.
-
The North Central London Integrated Care System (NCL ICS) has new services and staff training to support patients with inherited red cell disorders, including Sickle Cell and Thalassaemia, living in Barnet, Camden, Enfield, Haringey and Islington.
-
Patients with COVID-19 will be given the cystic fibrosis drug ‘Dornase alfa’ to determine if it can help improve survival by reducing excess inflammation in the lungs in a trial at UCLH.
-
UCLH is to trial a COVID-19 vaccine developed by Imperial College London.
File results
-
FOI/2022/0246 - Adult haematology services
-
FOI/2022/0247 - Care Axial SpA referrals to rheumatology
-
FOI/2022/0249 - Robotic process automation/ intelligent automation technology
-
FOI/2022/0263 - Rheumatology prescriptions
-
FOI/2022/0268 - Total bed management contract with Medstrom Ltd
-
FOI/2022/0269 - Allied health professionals job planning and junior doctor rotas software
-
FOI/2022/0273 - Proton therapy
-
FOI/2022/0275 - Biologic medications within dermatology
-
FOI/2022/0276 - Biologic medicines within dermatology
-
FOI/2022/0280 - Applications or tools to communicate digitally with patients